Alternative Definitions of Sarcopenia, Lower Extremity Performance, and Functional Impairment with Aging in Older Men and Women

By M. Delmonico, Tamara B. Harris, Jung‐Sun Lee, Marjolein Visser, M. Nevitt, Stephen B. Kritchevsky, Fran Tylavsky, A. Newman. Journal of The American Geriatrics Society, 2007

781 citations recorded by the source corpus.

Subfields: Geriatrics and Gerontology, Physiology

View Paper: https://www.semanticscholar.org/paper/a6329bb8dc92dbde35e8c85ebf49c635eb9f62f2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Geriatrics and Gerontology

1. Todd M. Manini
2. Brian C. Clark

In Physiology

1. Brian C. Clark
2. Tamara B. Harris
3. Todd M. Manini
4. R. Baumgartner
5. Anne B. Newman
6. Marco Narici

Citations in the corpus

• Sarcopenia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; a Quantitative Review (2012, background): “It failed to demonstrate increased compromise in lower limb function in sarcopenic men when sarcopenia was defined as low appendicular lean mass/height2 (Delmonico et al., 2007).”
• Sarcopenia: European consensus on definition and diagnosis (2010, background): “Sarcopenia is a syndrome characterised by progressive and generalised loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life and death [17, 18].”
• Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. (2011, background): “Sarcopenia is correlated with functional decline and disability (5, 16, 71, 76, 77).”
• Clinical definition of sarcopenia. (2014, background): “Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life and death (8, 9).”
• Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives (2008, methodology): “used a residual method, to adjust muscle mass for fat mass in addition to height (32), and found that this index had stronger associations with lower extremity functional limitation (32) and disability than sarcopenia defined by the SMI alone (34).”
• Dynapenia and aging: an update. (2012, background): “It should be noted that the addition of fat mass moderately improves the association with health outcomes (35,38).”